PB
Puma Biotechnology, Inc.
PBYI · NASDAQ
$9.60 +0.95% (+$0.09)
1M +5.38%
Market Cap $484.6M
P/E Ratio 18.14x
Div. Yield -
ROE 20.85%
Bulios Fair Price
$7.46
22.3% downside
Trenutna cena
$9.6
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PBYI trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
71 /100
Cheap P/E 18.14x
EV/EBITDA 9.50x
P/S 2.10x
Growth
63 /100
Stable EPS growth 210.89%
Rev. growth 0.05%
Book val. growth 82.03%
Profitability
81 /100
Strong Gross margin 74.83%
Net margin 11.55%
Op. margin 13.16%
Quality
95 /100
Excellent ROIC 18.20%
ROE 20.85%
ROA 13.86%
Debt
97 /100
Low Debt/Equity 0.03x
Current ratio 2.91x
Int. coverage 9.86x
Stability
55 /100
Moderate Beta 1.23x
Rev. volatility 2.89%
EPS volatility 1,211.83%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PBYI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alan H. Auerbach
Employees
179
Headquarters
Los Angeles
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report